Human and Microbial Determinants of the Onset of IBD Flares
ConditionIBD (Inflammatory Bowel Disease)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorViome
About this trial
This study will collect longitudinal biological samples and survey data to identify the triggers of IBD flares.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient at Universidade Federal de Santa Catarina (UFSC) Hospital, under care of Dr. Vivian Menegassi
Disqualifiers
Cancer Diagnosis/Treatment
Under 18 years old
Trial population
Adults diagnosed with Crohn's Disease or Ulcerative Colitis that are patients at Universidade Federal de Santa Catarina (UFSC) Hospital and under care of Dr. Vivian Menegassi
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
100 Participants
are grouped into 1 trial groupGroup A: Inflammatory Bowel Disease (IBD)
Trial outcomes
Primary outcomes
1
Stool microbial KEGG orthologs (KOs) associated with IBD
Metatranscriptomic tests will be used to quantify microbial KOs in stool samples. At the end of the study, we will use machine learning to identify KOs whose expression is associated with IBD.
Time frame
For 12 months from enrollmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Viome
Lead sponsor
Universidade Federal de Santa Catarina
Collaborator
Source ClinicalTrials.gov